Evidence-Based Personalized Treatment for Depression (EBPT-MDD)
About the Study:
The Evidence-Based Personalized Treatment for Depression Study (EBPT-MDD) is a research study aimed at collecting pilot data to assess the effectiveness of a therapist-led personalized intervention for Major Depressive Disorder (MDD). This study could help us to improve clinical outcomes for people with MDD by tailoring treatment based on individual symptom profiles. Eligible participants must have current MDD symptoms, own a smart phone, live in the USA, and are aged 18-65.
If after participating in the study’s pre-screening phase, which consists of a 10–15-minute online assessment, an individual is eligible to continue their participation to the main study phase, the main phase will begin with a virtual intake interview that involves a second screening process. If you are then deemed eligible to continue participating beyond the virtual intake interview, you will be able to continue participation to the remaining study procedures. The remaining study procedures consists of 5 parts:
Participants will receive up to $165 in incentives/financial compensation for completing study procedures beyond the online pre-screening and the virtual intake interview:
Frequently Asked Questions:
How do I know if I qualify for this study?
Where does the study take place?
All study procedures take place online over secure virtual teleconference software or secure University provided questionnaire service.
How long does the whole study take?
The total time of the study will be approximately 18 weeks.
What are the benefits of participation?
Answering surveys about mood, anxiety, and depression symptoms may cause awareness and increase self-monitoring of cognitions and behaviors. Participants will get 10 sessions of free depression treatment, which may decrease depression symptoms over the course of the study. Additionally, participants will receive free treatment and up to $165 in incentives/financial compensation for completing all portions of the study. Your participation in this study could also benefit others by helping us develop more effective evidence-based treatment for depression.
Are there any risks associated with participating?
During screening, you may be asked about sensitive topics such as depression and anxiety symptoms. You may experience discomfort during treatment sessions due to them targeting these sensitive topics, but all of our therapists are trained to address client distress. Also, this discomfort may lead to a decrease in your depression symptoms. If you become upset outside of the screenings or treatment, Dr. Vanzhula will be on-call to provide resources to you. Also, you can end your participation in this study at any point.
Who can I contact for more information?
If you are interested in participating in the study, please complete the prescreener and a member of our research staff will contact you if you are eligible. If you have any questions or concerns you can email us at [email protected]. Contact us to participate!
About the Study:
The Evidence-Based Personalized Treatment for Depression Study (EBPT-MDD) is a research study aimed at collecting pilot data to assess the effectiveness of a therapist-led personalized intervention for Major Depressive Disorder (MDD). This study could help us to improve clinical outcomes for people with MDD by tailoring treatment based on individual symptom profiles. Eligible participants must have current MDD symptoms, own a smart phone, live in the USA, and are aged 18-65.
If after participating in the study’s pre-screening phase, which consists of a 10–15-minute online assessment, an individual is eligible to continue their participation to the main study phase, the main phase will begin with a virtual intake interview that involves a second screening process. If you are then deemed eligible to continue participating beyond the virtual intake interview, you will be able to continue participation to the remaining study procedures. The remaining study procedures consists of 5 parts:
- Initial baseline questionnaire
- 15 days of shorter online questionnaires via your mobile phone (5x a day)
- 10 sessions of Personalized Treatment for Depression over Zoom or TEAMS with a trained clinician
- Post-treatment questionnaire directly after session 10
- One-month post treatment questionnaire
Participants will receive up to $165 in incentives/financial compensation for completing study procedures beyond the online pre-screening and the virtual intake interview:
- Initial baseline questionnaire: $30
- Shorter, online questionnaires: up to $75 (prorated based on completion rate)
- Post treatment questionnaire: $30
- One-month follow up: $30
Frequently Asked Questions:
How do I know if I qualify for this study?
- Current depression symptoms
- Speak/read/write English fluently
- 18-65 years old
- Own a smartphone
- Live in the United States
- If you think you might qualify, please review the prescreening phase’s online consent document, located at the following URL (from which you can proceed to the presecreener survey): https://redcap.link/5289cmgk
Where does the study take place?
All study procedures take place online over secure virtual teleconference software or secure University provided questionnaire service.
How long does the whole study take?
The total time of the study will be approximately 18 weeks.
- 1-2 weeks for eligibility screenings and assessments
- 15 days of daily questionnaires
- 10 weeks of therapist-led sessions
- Post treatment questionnaire (given 2 weeks to complete)
- One-month post-assessment questionnaire (given 2 weeks to complete)
What are the benefits of participation?
Answering surveys about mood, anxiety, and depression symptoms may cause awareness and increase self-monitoring of cognitions and behaviors. Participants will get 10 sessions of free depression treatment, which may decrease depression symptoms over the course of the study. Additionally, participants will receive free treatment and up to $165 in incentives/financial compensation for completing all portions of the study. Your participation in this study could also benefit others by helping us develop more effective evidence-based treatment for depression.
Are there any risks associated with participating?
During screening, you may be asked about sensitive topics such as depression and anxiety symptoms. You may experience discomfort during treatment sessions due to them targeting these sensitive topics, but all of our therapists are trained to address client distress. Also, this discomfort may lead to a decrease in your depression symptoms. If you become upset outside of the screenings or treatment, Dr. Vanzhula will be on-call to provide resources to you. Also, you can end your participation in this study at any point.
Who can I contact for more information?
If you are interested in participating in the study, please complete the prescreener and a member of our research staff will contact you if you are eligible. If you have any questions or concerns you can email us at [email protected]. Contact us to participate!
